Kouchkovsky, I. D., Moradpour, M., Zhang, L., Tuchayi, A. M., Zhu, X., Juarez, R., Kwon, D., Koshkin, V. S., Chou, J., Friedlander, T. W., Small, E. J., Aggarwal, R. R., Hope, T. A. (2025). Impact of baseline PSMA PET in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) starting first-line (1L) androgen receptor signaling inhibitor (ARSI) therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.46